Investor site visit

RNS Number : 4099C
Surgical Innovations Group PLC
01 May 2012
 



 

1 May 2012

Surgical Innovations Group plc

("SI" or the "Company")

 

Investor site visit

 

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), will be hosting an investor site visit for institutional investors today at its manufacturing facility in Leeds.

 

No new trading or financial information will be disclosed during the visit.

 

- ENDS -

 

Enquiries:

 

Surgical Innovations Group plc

www.sigroupplc.com

Doug Liversidge, Non-Executive Chairman

 

Graham Bowland, Chief Executive Officer

Tel: +44 (0) 113 230 7597

graham.bowland@surginno.co.uk

 

 

Seymour Pierce Limited

www.seymourpierce.com

Freddy Crossley / Sarah Jacobs (Corporate Finance)

Tel: +44 (0) 20 7107 8000

David Banks / Jacqui Briscoe (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com

Fiona Henson

Mob: 07886 335 992 or fiona.henson@walbrookpr.com

 

 

 

 



 

Notes to Editors:

 

About Surgical Innovations Group plc

 

Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 

 

As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

 

Over 120 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.

 

The Group's patented products are sold through three main channels:

 

SI brand

Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent. 

 

OEM and IP

The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion. 

 

Industrial

 

SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime. 

 

For more information, see www.sigrouplplc.com

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKLEDFNAEFF
UK 100